Quantum X Labs Inc. (QXL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the QXL SEC filings page.
This page shows Quantum X Labs Inc. (QXL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The latest data depict cash strain and earnings deterioration despite modest leverage, making liquidity—not debt the dominant operating mechanic.
Operating cash flow moved from positive$1.5M to-$2.8M across the latest two reported periods, a cash-conversion reversal. Current ratio likewise dropped from 0.6x to 0.4x, linking weaker cash generation with less short-term flexibility.
The latest net loss of
Debt-to-equity was 0.1x, but current ratio was 0.4x; the dominant balance-sheet constraint is near-term obligations rather than heavy long-term borrowing. FY2024 free cash flow nearly matched operating cash flow while capital expenditures were just
Financial Health Signals
Quantum X Labs Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Quantum X Labs Inc. passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Quantum X Labs Inc. reported a net loss of $19.3M while operations used $2.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Quantum X Labs Inc. reported an operating loss of $2.2M against $63K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Quantum X Labs Inc. generated $293K in revenue in Q2 2026. This represents a decrease of 87.2% from the same quarter a year earlier.
Quantum X Labs Inc.'s EBITDA was -$1.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 48.1% from the same quarter a year earlier. Against the prior quarter it is down 258.0%.
Quantum X Labs Inc. reported $2.5M in net income in Q2 2026. This represents an increase of 121.3% from the same quarter a year earlier. Against the prior quarter it is up 510.7%.
Quantum X Labs Inc. earned $0.12 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 140.0%.
Cash & Balance Sheet
Quantum X Labs Inc. recorded an outflow of $1.2M in free cash flow in Q2 2026, representing a cash shortfall after capex.
Quantum X Labs Inc. held $2.4M in cash against $195K in long-term debt as of Q2 2026, with $4.0M of liabilities due within a year.
Not reported for Q2 2026.
Margins & Returns
Quantum X Labs Inc.'s ROE was 9.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 267.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.4 percentage points.
Not reported for Q2 2026.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Quantum X Labs Inc. invested $185K in research and development in Q2 2026. This represents an increase of 825.0% from the same quarter a year earlier.
Quantum X Labs Inc. invested $186K in capex in Q2 2026, funding long-term assets and infrastructure.
Not reported for Q2 2026.
QXL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $293K-87.2% | N/A | N/A | $2.7M-56.7% | $2.3M-68.9% | $2.7M-72.7% | $3.3M-79.1% | $6.3M-60.0% |
| R&D Expenses | $185K+825.0% | N/A | N/A | $115K-66.0% | $20K-96.2% | $16K-97.8% | -$770K+13.2% | $338K-51.7% |
| SG&A Expenses | $1.0M+81.9% | $500K+153.8% | N/A | $619K+42.3% | $558K-13.6% | $197K-70.0% | $116K-84.7% | $435K-40.2% |
| Operating Income | -$1.4M-36.4% | -$550K-900.0% | N/A | -$3.6M-301.0% | -$1.0M+81.3% | -$55K+94.6% | $6.6M+209.4% | -$906K+45.2% |
| EBITDA | -$1.2M-48.1% | -$326K-376.3% | N/A | -$2.8M-1487.7% | -$788K+83.1% | $118K+142.6% | $5.1M+197.1% | -$179K+80.5% |
| Interest Expense | N/A | N/A | N/A | $81K-43.0% | $122K-38.4% | $38K-2.6% | -$219K | $142K |
| Income Tax | -$94K-40.3% | -$16K-138.1% | N/A | -$348K-489.8% | -$67K-179.2% | $42K+4100.0% | $213K+300.9% | -$59K+55.0% |
| Net Income | $2.5M+121.3% | -$605K+83.5% | N/A | -$3.4M-475.1% | -$11.7M-62.4% | -$3.7M-267.2% | -$3.3M+37.9% | -$590K+60.9% |
| EPS (Basic) | $0.17+110.6% | $0.05-92.6% | -$0.14-104.4% | $0.32+166.7% | -$1.61-184.3% | $0.68+151.9% | $3.21+52.1% | $0.12+220.0% |
| EPS (Diluted) | $0.12 | $0.05 | -$0.14 | $0.32 | -$1.61-184.3% | $0.68+151.9% | $3.21+52.1% | $0.12+220.0% |
| Diluted Shares (Avg) | 20M | 11M | N/A | 10M | 7M+92.2% | 5M+45.1% | N/A | 5M-65.8% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.
QXL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.2M+55.1% | $27.7M+4.9% | $10.8M-51.0% | $16.9M-45.2% | $20.1M-33.0% | $26.4M-29.6% | $22.0M-49.2% | $30.8M-38.6% |
| Current Assets | $3.5M-15.6% | $2.9M-55.6% | $1.7M-78.7% | $4.1M-68.2% | $4.1M-63.5% | $6.5M-49.1% | $7.8M-56.5% | $12.9M-31.2% |
| Cash & Equivalents | $2.4M+22.5% | $1.8M+890.6% | $1.0M+4141.7% | $2.2M+54.1% | $2.0M+226.4% | $181K-85.9% | $24K-98.6% | $1.4M-44.9% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $281K-73.2% | $355K-65.8% | $315K-43.4% | $1.3M-78.2% | $1.0M-82.7% | $1.0M-85.2% | $557K-95.1% | $6.1M-47.0% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $20.7M+216.2% | $20.7M+113.5% | $6.4M+490.2% | $6.2M-17.4% | $6.6M-12.8% | $9.7M-20.8% | $1.1M-91.2% | $7.5M-56.7% |
| Total Liabilities | $5.4M-65.4% | $6.1M-68.1% | $5.8M-64.4% | $11.3M-47.9% | $15.6M-32.1% | $19.1M-19.2% | $16.2M-43.1% | $21.8M-27.6% |
| Current Liabilities | $4.0M-68.0% | $4.2M-72.4% | $4.1M-68.6% | $8.6M-49.5% | $12.7M-18.4% | $15.4M-3.4% | $12.9M-34.6% | $16.9M-17.8% |
| Non-Current Liabilities | $1.3M-36.8% | $1.8M-20.3% | $1.7M+11.4% | $2.5M+10.0% | $2.1M-56.0% | $2.2M-46.3% | $1.5M-68.7% | $2.3M-49.0% |
| Long-Term Debt | $195K | $390K | $586K+18.1% | $781K-27.7% | N/A | N/A | $496K-83.8% | $1.1M-59.4% |
| Total Equity | $25.8M+470.0% | $21.6M+197.5% | $5.0M-13.6% | $5.6M-38.6% | $4.5M-36.0% | $7.3M-47.5% | $5.8M-61.1% | $9.0M-55.0% |
| Retained Earnings | -$44.2M-4.9% | -$46.7M-76.8% | -$46.0M-102.7% | -$45.5M-134.1% | -$42.1M-123.4% | -$26.4M-126.3% | -$22.7M-113.1% | -$19.4M-261.8% |
Not reported in any period shown, so not listed: Inventory.
QXL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.1M-148.7% | -$604K-47.7% | -$218K+51.2% | -$1.7M-421.2% | -$427K-131.7% | -$409K-482.2% | -$447K-329.2% | $534K+293.5% |
| Depreciation & Amortization | $228K-3.0% | $224K+29.5% | -$1.4M+1.8% | $791K+8.8% | $235K-71.4% | $173K-76.4% | -$1.5M-295.9% | $727K-1.0% |
| Stock-Based Compensation | N/A | N/A | N/A | N/A | $75K+581.8% | $3K-83.3% | N/A | $61K+41.9% |
| Capital Expenditures | $186K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | -$1.2M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | $0 | $0 | $12K | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | $1.9M+634.7% | $2.3M+213.5% | -$45K+93.2% | -$317K+68.4% | $262K+155.4% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
QXL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -476.1% | N/A | N/A | -133.7% | -44.9%+29.9pp | -2.0%+8.1pp | 197.3% | -14.4%-3.9pp |
| Net Margin | 848.1% | N/A | N/A | -124.9% | -511.1% | -134.2% | -98.9%-65.5pp | -9.4%+0.2pp |
| Return on Equity | 9.6%+267.4pp | -2.8%+47.7pp | N/A | -61.1%-54.5pp | -257.8%-156.3pp | -50.5%-43.3pp | -57.0%-21.2pp | -6.5%+1.0pp |
| Return on Assets | 8.0%+66.0pp | -2.2%+11.7pp | N/A | -20.1%-18.2pp | -58.0%-34.1pp | -13.9%-11.2pp | -15.0%-2.7pp | -1.9%+1.1pp |
| Current Ratio | 0.86+0.5x | 0.68+0.3x | 0.41-0.2x | 0.48-0.3x | 0.33-0.4x | 0.42-0.4x | 0.60-0.3x | 0.76-0.1x |
| Debt-to-Equity | 0.01-3.4x | 0.02-2.6x | 0.120.0x | 0.140.0x | 3.44+3.2x | 2.64+2.5x | 0.09-0.1x | 0.120.0x |
| Asset Turnover | 0.01-0.1x | N/A | N/A | 0.160.0x | 0.11-0.1x | 0.10-0.2x | 0.15-0.2x | 0.20-0.1x |
| FCF Margin | -425.9% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: The current ratio is below 1.0 (0.41), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where Quantum X Labs Inc. Ranks
Frequently Asked Questions
Is Quantum X Labs Inc. profitable?
No, Quantum X Labs Inc. (QXL) reported a net income of -$19.3M in fiscal year 2025.
What is Quantum X Labs Inc.'s EBITDA?
Quantum X Labs Inc. (QXL) had EBITDA of -$1.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Quantum X Labs Inc. have?
As of fiscal year 2025, Quantum X Labs Inc. (QXL) had $1.0M in cash and equivalents against $586K in long-term debt.
What is Quantum X Labs Inc.'s return on equity (ROE)?
Quantum X Labs Inc. (QXL) has a return on equity of -386.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Quantum X Labs Inc.'s operating cash flow?
Quantum X Labs Inc. (QXL) recorded an outflow of $2.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Quantum X Labs Inc.'s total assets?
Quantum X Labs Inc. (QXL) had $10.8M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Quantum X Labs Inc. spend on research and development?
Quantum X Labs Inc. (QXL) invested $69K in research and development during fiscal year 2025.
What is Quantum X Labs Inc.'s current ratio?
Quantum X Labs Inc. (QXL) had a current ratio of 0.41 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Quantum X Labs Inc.'s debt-to-equity ratio?
Quantum X Labs Inc. (QXL) had a debt-to-equity ratio of 0.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Quantum X Labs Inc.'s return on assets (ROA)?
Quantum X Labs Inc. (QXL) had a return on assets of -179.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Quantum X Labs Inc.'s P/E ratio?
Quantum X Labs Inc. (QXL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $73.9M as of Sep 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Quantum X Labs Inc.'s price-to-sales ratio?
Quantum X Labs Inc. (QXL) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $73.9M as of Sep 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Quantum X Labs Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Quantum X Labs Inc. (QXL) held $1.0M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.8M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Quantum X Labs Inc.'s Piotroski F-Score?
Quantum X Labs Inc. (QXL) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Quantum X Labs Inc.'s earnings high quality?
Quantum X Labs Inc. (QXL) reported a net loss of $19.3M while operations used $2.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Quantum X Labs Inc. cover its interest payments?
Quantum X Labs Inc. (QXL) reported an operating loss of $2.2M against $63K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.